Higher elimination rate of hepatitis C virus among women

Journal of Viral Hepatitis

Volumn 3, Issue 6, 1996, Pages 317-321

  Yamakawa, Y ^a   Sata, M ^a   Suzuki, H ^a   Noguchi, S ^a   Tanikawa, K ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gender; HCV RNA; Hepatitis C; Polymerase chain reaction

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL DERIVATIVE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; METABOLISM; MIDDLE AGED; OBESITY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ALCOHOLS; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; OBESITY; RNA, VIRAL;

EID: 0030278189     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2893.1996.tb00104.x     Document Type: Article

References (19)

1. Kiyosawa K, Furuta S. Review of hepatitis C in Japan. J Gastroenterol Hepatol 1991; 6: 383-391.
2. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
3. Ikeda K, Saitoh S, Koida I et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18: 47-53.
4. Hopf U, Moller B, Kuther D et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10: 69-76.
5. Garson JA, Tedder RS, Briggs M et al. Detection of hepatitis C viral sequences in blood donations by 'nested' polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-1422.
6. Farci P, Alter HJ, Wong D et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis (see comments). N Engl J Med 1991; 325: 98-104.
7. Inchauspe G, Abe K, Zebedee S, Nasoff M, Prince AM. Use of conserved sequences from hepatitis C virus for the detection of viral RNA in infected sera by polymerase chain reaction. Hepatology 1991; 14: 595-600.
8. Okamoto H, Okada S, Sugiyama Y et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jap J Exp Med 1990; 60: 215-222.
9. Fujimoto IK, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47: 4967-4972.
10. Nishioka K, Watanabe J, Furuta S et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429-433.
11. Yoshizawa H, Tanaka J, Ohhori K et al. Prevalence of the HCV associated markers among blood donors in Japan. Nippon Rinsho 1991; 49: 357-365.
12. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325: 1325-1329.
13. Marcellin P, Martinot PM, Boyer N et al. Second generation (RIBA) test in diagnosis of chronic hepatitis C (letter) (see comments). Lancet 1991; 337: 551-552.
14. Nishioka K. Hepatitis C virus infection in Japan. Gastroenterol Jap 1991; 3: 152-155.
15. Setoguchi Y, Yamamoto K, Ozaki I et al. Prevalence of chronic liver diseases and anti-HCV antibodies in different districts of Saga, Japan. Gastroenterol Jap 1991; 26: 157-161.
16. Kiyosawa K, Tanaka E, Sodeyama T et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 1994; 106: 1596-1602.
17. Caporaso N, Romano M, Marmo R et al. Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis. J Hepatol 1991; 12: 367-371.
18. Tanaka H, Hiyama T, Tsukuma H et al. Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data. Jap J Cancer Res 1994; 85: 485-490.
19. Mazzella G, Accogli E, Sottili S et al. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis. J Hepatol 1996; 24: 141-147.